<html>
<head>
  <title>Smarter Insulin, Healthier You: Analytics and Exploratory Data Analysis</title>
  <style>
    body {
      margin: 0 auto;
      width: 744px;
      font-family: Source Serif Pro, serif;
      line-height: 32px;
      font-weight: 400;
      color: rgba(0, 0, 0, 0.7);
      font-size: 21px;
    }
    h1, h2, h3 {
      font-family: Source Sans Pro, Helvetica, Arial, sans-serif;
    }
    h1 a, h1 a:visited {
      color: inherit;
      text-decoration: none;
    }
    h1 {
      line-height: 48px;
      font-weight: 600;
      color: rgba(0, 0, 0, 0.85);
      font-size: 42px;
      margin: 32px 0 20px;
    }
    h2 {
      line-height: 32px;
      font-weight: 600;
      color: rgba(0, 0, 0, 0.85);
      font-size: 26px;
      margin: 28px 0;
    }
    h3 {
      line-height: 28px;
      font-weight: 600;
      color: rgba(0, 0, 0, 0.85);
      font-size: 21px;
      margin: 24px 0;
    }
    p {
      margin: 32px 0;
    }
    .created, .published {
      color: rgba(0, 0, 0, 0.55);
      font-size: 15px;
      line-height: 15px;
      margin: 20px 0;
    }
    .created + .published {
      margin-top: -12px;
    }
    blockquote {
      font-family: Georgia, Source Serif Pro, serif;
      font-style: italic;
      font-size: 24px;
      line-height: 36px;
      margin: 48px 120px;
      text-align: center;
    }
    a {
      word-wrap: break-word;
      outline: none;
      text-decoration: none;
      background-color: transparent;
      border: 0;
      color: #008CC9;
    }
    a:hover {
      text-decoration: underline;
    }
    a:visited {
      color: #8C68CB;
    }
    .center {
      text-align: center;
    }
    iframe {
      display: block;
      margin: 44px auto;
    }
    *:not(pre) + pre, pre:first-of-type {
      margin-top: 32px;
      padding-top: 32px;
    }
    pre:only-of-type {
      margin: 32px 0;
      padding: 32px;
    }
    pre {
      background: #F3F6F8;
      overflow-x: auto;
      display: block;
      font-size: 13px;
      font-family: monospace;
      line-height: 13px;
      padding: 0 32px 32px;
      white-space: pre;
    }
    a.embedded {
      background: #F3F6F8;
      display: block;
      padding: 32px;
      margin: 32px 0;
    }
    img {
      height: auto;
      max-width: 100%;
    }
    .slate-image-embed__resize-full-width img {
      width: 100%;
    }
    .series-logo {
      width: 48px;
      height: 48px;
      box-sizing: border-box;
      background-clip: content-box;
      border: 4px solid transparent;
      border-radius: 6px;
      object-fit: scale-down;
      float: left;
    }
    .series-title {
      font-size: 16px;
      font-weight: 600;
      vertical-align: top;
    }
    .series-description {
      color: rgba(0,0,0,.6);
      font-weight: 400;
      font-size: 14px;
      line-height: 20px;
    }
    div {
      margin: 32px 0;
    }
  </style>
</head>
<body>
    <img src="https://media.licdn.com/mediaD5612AQG0fPkX3teRXA" alt="" title="" />
      <h1><a href="https://www.linkedin.com/pulse/smarter-insulin-healthier-you-analytics-exploratory-data-paddy-iyer-ld3cc">Smarter Insulin, Healthier You: Analytics and Exploratory Data Analysis</a></h1>
    <p class="created">Created on 2024-02-04 01:54</p>
  <p class="published">Published on 2024-02-04 02:01</p>
  <div><figure><img data-media-urn="urn:li:digitalmediaAsset:D5612AQFqlizBv9IYiw" src="https://media.licdn.com/dms/image/v2/D5612AQFqlizBv9IYiw/article-inline_image-shrink_400_744/article-inline_image-shrink_400_744/0/1707011722370?e=1773878400&amp;v=beta&amp;t=eWsS4axhLuf2K-IP6H8OjtAJjH-Nul6pNJwvLVkFx-Y"><figcaption></figcaption></figure><h3>3.1 Analytics Goals and Use Cases:</h3><ul><li><p>Evaluate patient progress: Track blood sugar control, identify trends, and assess response to therapy adjustments.</p></li><li><p>Optimize insulin delivery: Analyze glucose patterns and device settings to personalize insulin delivery for better control.</p></li><li><p>Predict potential complications: Identify early warning signs of hypoglycemia or hyperglycemia for proactive intervention.</p></li><li><p>Improve user experience: Analyze app usage patterns and feedback to enhance usability and adherence.</p></li><li><p>Generate clinical insights: Support research and development of improved treatment strategies for diabetes management.</p></li></ul><h3>3.2 Exploratory Data Analysis (EDA):</h3><ul><li><p>Descriptive statistics: Summarizing key metrics like average glucose levels, insulin dosage, and app usage frequency.</p></li><li><p>Data visualization: Creating charts and graphs to visualize trends, relationships, and outliers in the data.</p></li><li><p>Correlation analysis: Identifying potential relationships between glucose levels, insulin delivery, patient activity, and other factors.</p></li></ul><h3>3.3 Advanced Analytics and Machine Learning:</h3><ul><li><p>Time series analysis: Forecasting future glucose levels based on historical trends and device settings.</p></li><li><p>Clustering: Grouping patients with similar characteristics to personalize treatment approaches.</p></li><li><p>Predictive modeling: Identifying patients at high risk of complications for targeted interventions.</p></li></ul><h2>Deeper Analysis of Wearable Insulin Switchers</h2><h3>Segmentation L1.. L8</h3><ul><li><p>L1: Time to treatment discontinuation: Track how long patients stay on wearable insulin before stopping.</p></li><li><p>L2: Time to complication: Monitor the occurrence of any related complications during treatment.</p></li><li><p>L3: Glycemic control improvement: Measure changes in HbA1c or other blood sugar metrics after switching.</p></li><li><p>L4: Healthcare utilization: Analyze hospital visits, ER admissions, or other healthcare resource use.</p></li><li><p>L5: Treatment adherence: Assess how consistently patients use the wearable insulin device.</p></li><li><p>L6: Patient satisfaction: Collect feedback on treatment experience and satisfaction.</p></li><li><p>L7: Cost-effectiveness: Evaluate the cost of wearable insulin compared to other treatment options.</p></li><li><p>L8: Quality of life: Measure the impact of treatment on patients’ overall well-being and daily activities.</p></li></ul><p><strong>Segmentation Types:</strong></p><ul><li><p>Demographic segmentation: Analyze differences based on age, gender, ethnicity, etc.</p></li><li><p>Clinical segmentation: Group patients by diabetes severity, comorbidities, or other relevant factors.</p></li><li><p>Behavioral segmentation: Segment based on treatment adherence, healthcare utilization, or other behavior patterns.</p></li></ul><h3>EDA for HbA1c Improvement/Deterioration in Wearable Insulin Switchers</h3><p>Here’s how you can conduct an Exploratory Data Analysis (EDA) to understand HbA1c changes in patients who switched to wearable insulin, focusing on factors that might influence improvement or deterioration:</p><p><strong>1. Data Preparation:</strong></p><ul><li><p>Ensure relevant data tables are clean and well-organized. This includes tables for:</p></li><li><p><strong>Patients:</strong> Demographics, diagnoses, etc.</p></li><li><p><strong>Treatments:</strong> Details of wearable insulin and other treatments.</p></li><li><p><strong>Lab Results:</strong> HbA1c measurements before, during, and after the switch.</p></li><li><p><strong>Additional Factors:</strong> Potential influencing factors like age, comorbidities, treatment adherence, etc. (if available).</p></li></ul><p><strong>2. Initial Exploration:</strong></p><ul><li><p><strong>Descriptive Statistics:</strong> Calculate basic statistics (mean, median, standard deviation) for HbA1c values before and after the switch.</p></li><li><p><strong>Visualization:</strong> Create histograms or boxplots to visualize the distribution of HbA1c changes across the entire population.</p></li></ul><p><strong>3. Segmentation Analysis:</strong></p><ul><li><p>Segment patients based on:</p></li><li><p><strong>HbA1c Change:</strong> Group by improvement, no change, or deterioration.</p></li><li><p><strong>Potential Influencing Factors:</strong> Segment by demographics, clinical factors, treatment details, etc.</p></li><li><p><strong>Compare HbA1c Changes:</strong> Compare mean/median HbA1c changes across segments using boxplots or violin plots.</p></li></ul><p><strong>4. Visualization and Insights:</strong></p><ul><li><p><strong>Line Charts:</strong> Track individual patient trends in HbA1c over time, highlighting improvement/deterioration patterns.</p></li><li><p><strong>Scatterplots:</strong> Explore relationships between potential influencing factors and HbA1c changes (e.g., age vs. HbA1c improvement).</p></li><li><p><strong>Heatmaps:</strong> Identify potential correlations between multiple influencing factors and HbA1c changes.</p></li></ul><p><strong>5. Deeper Analysis:</strong></p><ul><li><p><strong>Survival Analysis:</strong> Use Kaplan-Meier curves to compare the time to HbA1c improvement/deterioration across segments.</p></li><li><p><strong>Multivariate Analysis:</strong> Use regression techniques (e.g., logistic regression) to identify significant predictors of HbA1c improvement/deterioration, considering multiple influencing factors simultaneously.</p></li></ul><p><strong>6. Considerations:</strong></p><ul><li><p><strong>Data Quality:</strong> Ensure accurate and complete data in all relevant tables.</p></li><li><p><strong>Clinical Interpretation:</strong> Consult healthcare professionals to interpret findings in the context of clinical guidelines and individual patient factors.</p></li><li><p><strong>Ethical Considerations:</strong> Maintain data privacy and avoid drawing conclusions that violate ethical principles.</p></li></ul><h2>Sample codes:</h2><h3>Switching from Pill to Insulin Pump Analysis:</h3><p><strong>1. Identify Metformin Users:</strong></p><pre></pre><p>This query retrieves patient information (ID, name) for those currently taking Metformin, identified by either the specific code or description containing “Metformin”. The  condition ensures we only consider active treatments.</p><p><strong>2. Identify Wearable Insulin Users:</strong></p><pre></pre><p>This query retrieves patient information for those currently using wearable insulin treatments, identified by the  field in the  table.</p><p><strong>3. Find Metformin to Wearable Insulin Switchers:</strong></p><pre></pre><h3>Segmentation Analysis:</h3><p><strong>L1: Time to treatment discontinuation:</strong></p><pre></pre><p>Segmentation: You can add  clauses based on desired demographic or clinical factors from  or linked tables.</p><p><strong>L3: Glycemic control improvement:</strong></p><pre></pre><p><strong>HbA1c over Time:</strong></p><pre></pre><p><strong>Churn, Return, and Retention:</strong></p><pre></pre></div>
</body>
</html>